Jaundice, Obstructive
18
0
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.6%
1 terminated out of 18 trials
90.0%
+3.5% vs benchmark
11%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (18)
Antimicrobial Resistance in Acute Cholangitis
A RCT of Low MBO Drainage Strategies
Immediate vs. Elective Endoscopic Removal of Large CBD Stones in High-Risk Elderly Patients
A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles
Microbiological Assessment of Bile in Patients Undergone to Endoscopic Retrograde Cholangiography (ERCP): the "Microbile Registry"
preGallstep - A Clinical Pilot Trial
Multicenter RCT for BIliary Brushing: RX Cytology, BOSTON vs. Infinity®, US Endoscopy
Endoscopic Versus Radiologic Biliary Drainage for Perihilar Malignant Obstruction
Bile Duct Injury Digestif
Remaxol® in Mechanical Jaundice of Non-malignant Origin
EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice
Process Optimization of Preoperative Biliary Drainage in Patients With Malignant Obstructive Jaundice
Endoscopic Access Loop With Bilio-enteric Anastomosis: A Prospective Randomized Comparison Between Gastric and Subcutaneous Accesses
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
Biliary Cannulation During Endoscopic Retrograde Cholangiopancreatography: Precut Versus Conventional Cannulation
Covered vs. Uncovered SEMS for Occluded Biliary Metal Stents
Cholinergic Anti-inflammatory Pathway in Prevention & Treatment of the SIRS in Patients With Jaundice After Operation.
Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)